{"version":"1.2.0","chapters":[{"startTime":0,"title":"Intro"},{"startTime":32.152999999999999,"title":"Begr\u00fc\u00dfung"},{"startTime":79.102999999999994,"title":"Lars Fischer"},{"startTime":189.69200000000001,"title":"Faszination f\u00fcr Viren und Seuchen"},{"startTime":384.995,"title":"Stand der Dinge bei SARS-Cov-2"},{"startTime":1184.4380000000001,"title":"Der PCR-Test"},{"startTime":1299.722,"title":"Inaktivierte Viren"},{"startTime":2053.8069999999998,"title":"DNA\/RNA und Vektorimpfstoffe"},{"startTime":2679.759,"title":"Lebendimpfstoffe"},{"startTime":2817.4760000000001,"title":"Virus\u00e4hnliche Partikel"},{"startTime":2960.8400000000001,"title":"Welche Impfstoffe k\u00f6nnen helfen?"},{"startTime":3417.123,"title":"M\u00f6gliche negative Auswirkungen"},{"startTime":3584.422,"title":"Impfstoffentwicklung in Deutschland"},{"startTime":3904.491,"title":"Ausblick"},{"startTime":4284.0690000000004,"title":"Mutation und Behandlungsoptionen"},{"startTime":4670.71,"title":"Ausklang"}]}